ABSTRACT
of signature genes and the gene set can be explained by a random distribution of genes or not. If 'not', then the 'guilt by association' assumption (Quackenbush, 2003) suggests an associative relation between the functional context of the gene set and the extracted list of genes supporting interpretation of the data in terms of biological knowledge.
There are two complementary approaches to compute enrichment: 'Overrepresentation' estimates the probability to find members of a given set in a signature list compared with their random appearance. Particularly, in gene set overrepresentation analysis, each gene studied is classified according to two memberships in the gene sets and/or signature list leading to a 2×2 contingency table for further testing using Fishers exact test.
Contrarily, 'overexpression' is used to characterize deviations between the mean expression score averaged over the gene set-members compared with the mean score of all genes.
The so-called gene set Z-score (GSZ) merges both options provided by the gene set overrepresentation and the gene set overexpression approaches (Toronen, Ojala, Marttinen, & Holm, 2009 ). Namely, the GSZ score is designed in such a way that members of the list with high expression scores more heavily contribute than members with lower values (see (Wirth, von Bergen, & Binder, 2012) for details). In practical applications the GSZ-enrichment score outperforms pure overrepresentation and overexpression estimates in terms of robustness and sensitivity (Toronen, et al., 2009; Wirth, et al., 2012) . For illustration, we consider two special cases of the GSZ-score referring to overexpression and overrepresentation, respectively:
1. If the gene list contains all the genes studied, one gets the GSZ-overexpression score as: where log E are log-expression scores, # stands for 'number of…' and angular brackets denote arithmetic averaging. It represents a Z-statistic estimating the overexpression in terms of deviation of the set average of the expression score from its total average over all genes where the standard error in the denominator is estimated using the variance of the set genes.
2. If all the expression scores in the list are equal, then one gets the GSZ-overrepresentation score as: It represents a Z-statistic estimating overrepresentation in terms of deviation between the observed and expected number of overlap genes where the standard error is estimated using the gene numbers in the list, the set and of all the genes.
Pathway Signal Flow Analysis
The Pathway Signal Flow (PSF) algorithm can be used to assess the changes in activity of a given biological pathway depending on the pathway topology and relative gene expression (Arakelyan, 2013) . As a pathway, we consider a directed graph of protein-protein interactions, which has several input or source nodes and output or sink nodes, with intermediate nodes and branches in-between. The input nodes sense an activating signal and pass it through interactions between intermediate node pairs to the sink nodes leading to functional realization of associated biological processes. We name this process of signal propagation in a pathway its signal flow. The more changes in the pathway flow are observed, the more it is likely that the given pathway is involved in the biological processes underlying the phenotypic differences between the conditions studied.
To evaluate the signal flow in a pathway, PSF-method explicitly takes into account the pathway topology and gene expression/protein levels of member nodes. Topology is an important characteristic of a pathway and is pivotal for its functioning. The terminal (source and sink) genes seem to be more important from the viewpoint of signal transduction, than genes located in the middle of the pathway. On the other hand, pathway branching and mean number of interactions per node may also highly influence gene-expression dependent signal transduction. The expression level of individual genes/gene products in the pathway is the next parameter influencing pathway state. Expression estimates the amount of mRNA that has been synthesized from the given gene, and is used as a marker of gene activity. . The relative expression (fold change) of a node used in PSF algorithm is calculated as the mean of the relative expression of all items in the given node. PSF accounts for fold change and pathway topology via signal propagation rules, shown in Figure 3 .
Thus, the PSF method combines previous knowledge in terms of pathway topologies with the relative expression data of the involved genes and estimates the information flow along the. The signal value at each of the nodes then provides information of the activity of associated biological functions.
The PSF algorithm takes as input pathway topologies represented as graph objects and a numerical vector representing gene expression/protein levels or any other activity indicator of biological entities. Graph structure representations of pathways are usually stored in machinereadable formats, usually, as xml files. For KEGG pathway images, graph structures are stored in KGML (KEGG pathway xml format) files that can be used for automated analysis of pathways (Kanehisa & Goto, 2000) . Using our R program, we parsed 168 KEGG pathways and stored them as a collection of KEGG graph objects. This collection was further used in analysis and visualization of pathway states in chosen conditions.
Generation of Gene Lists and Gene Set Mapping Using SOM Portrayal
Lists of signature genes can be generated in many ways by applying different methods of feature selection (Opgen-Rhein & Strimmer, 2007) . Here we apply the method of expression portrayal which is based on machine learning using self-organizing maps (Kohonen, 1982) . This algorithm serves as very effective 'sorting machine' that clusters the genes on two levels, namely the metagene and expression module levels H Binder & Wirth, 2014; Wirth, Loeffler, von Bergen, & Binder, 2011) . Usually one has to analyze gene-centered expression values in a series of a few to thousands of samples. Then the SOM method translates about 20,000 gene expression profiles (expression vectors of single genes in all the samples) into 1,000 -3,000 metagene expression profiles. The metagene expression levels are visualized for each sample as a two-dimensional mosaic grid serving as fingerprint portrait of its expression landscape. SOM size and topology has to be chosen to allow for robust identification of expression modules inherent in the data as described previously (Wirth, et al., 2011; Wirth, et al., 2012) . They were determined using either an expression threshold providing so-called overexpression spot modules, K-means clustering, distance map clustering, or a correlation measure. Significance of differential expression of genes included in the module clusters was estimated using t-testing and false discovery rate based multi-test adjustment (Wirth, et al., 2012) . The module clusters then provide lists of signature genes which were further processed in terms of gene set enrichment analysis. The method will be illustrated in the results section below.
Availability: PSF and GSA for oposSOM
The SOM portraying method is available as R-package 'oposSOM' from Bioconductor repository (Löffler-Wirth, Kalcher, & Binder, 2015) . oposSOM bundles a series of sophisticated analysis methods including gene set enrichment together with intuitive visualization options to study high-dimensional data with the special focus on gene-centered expression data. We currently extended these analysis options by a PSF-module, which considers 168 pathways taken from the KEGG library. The genes of each pathway were mapped onto the SOM grid allowing to percept their distribution with special regard to the overexpression spot regions; and vice versa, the genes in the pathway were assigned to respective spot modules. PSF-values were calculated for the nodes in each pathway and visualized in terms of pathway plots using red-to-blue color For gene set enrichment analyses we considered a large collection of gene sets (e.g. for human ≈8,500 sets) related to biological processes (BP), cellular components (CC) or molecular components (MC) taken from gene ontology (GO), standard literature sets as provided by the GSEA-repository (Subramanian, et al., 2005) and literature sets collected by us.
ONCOGENIC PATHWAYS ACTIVATION IN CELL LINE EXPERIMENTS
In this section we describe function discovery in gene expression data generated in a cell-line experiment on specific pathway activation. We will demonstrate how the expression patterns will be seen by SOM analysis, what biological functions can be extracted from gene set enrichment analysis, and we will illustrate the added value obtained from pathway analysis.
Experiment and Data
Gene expression signatures were identified in (Bild et al., 2006) that reflect the activation status of several oncogenic pathways. The study studied human primary mammary epithelial cell cultures (HMECs) to develop a series of pathway signatures. Cells were brought to quiescence, and then infected with adenovirus expressing either human c-Myc, activated H-Ras, human c-Src, human E2F3, or activated b-catenin. Expression data for each pathway activation type (MYC, SRC, BCAT, E2F3, RAS) and of non-activated controls (GFP) were recorded using GeneChip arrays as described in (Bild, et al., 2006) . These recombinant adenoviruses were used to express oncogenic activities in the otherwise quiescent cell, thereby specifically isolating the subsequent events as defined by the activation/deregulation of a single pathway. We downloaded the raw data from the public repository GEO, preprocessed them using our hook method (Hans Binder & Preibisch, 2008) and finally trained a SOM as described in (Wirth, et al., 2011) .
SOM Portrayal of Activated Pathways
SOM machine learning first generates a gallery of portraits characterizing each individual sample. We calculated mean portraits for each pathway activation by averaging over the 7 -9 replicates. The group portraits obtained express red and blue spot-like areas at different positions in the maps (Figure 4 , left part). Red and blue colors here mark overexpressed and underexpressed genes, respectively. The position of genes is identical in all portraits. One can therefore compare all group portraits each with another to identify genes overexpressed in one group and underexpressed in another group. For example, genes in the right lower corner of the map are upregulated in the controls, MYC, SCR and BCAT activated samples but downregulated in the RAS-group. The position of the respective key regulator gene is shown by a cross in each of the group portraits. Some of them (MYC, RAS, SCR) are located in the respective overexpression spots, thus indicating switching 'in phase' with activated genes. In contrast, E2F3 and BCAT are located in blue spots of genes underexpressed in the respective group, thus, indicating switching 'in anti-phase' with the activated genes. Moreover, E2F3 and BCAT are found virtually at the same positions of MYC and RAS, respectively. Co-location in the map means correlated and thus co-expressed profiles.
A series of supporting maps provide an overview over different properties of the group portraits (right part of Figure 4 ): The overexpression summary map projects all red overexpression spots into one map. These spots were segmented into clusters of coexpressed genes by applying an overexpression threshold criterion (Wirth, et al., 2011; Wirth, et al., 2012) . The spot summary map visualizes these segmented spot areas. The mean expression profiles of the genes of each spot are presented in a heatmap showing their groupwise over-and underexpression. For example, the abovementioned spot in the bottom right corner is assigned as spot 'K' showing blue underexpression in RAS-activated samples and yellow-brown overexpression in the other groups. Spot 'E' in the opposite top left corner shows the antagonistic profile being up in RAS and down in the other groups. The correlation map visualizes mutual correlations (green lines) and anticorrelations (red lines) between the spots (Figure 4 ). Adjacent spots are mostly correlated whereas spots from opposite borders of the map are mostly anticorrelated. Hence, the spot patterns of the map can be understood as a network of co-regulated gene modules where their number can serve as a rough estimate of the complexity of mutual wirings between them. The SOM algorithm uses Euclidian distance between the expression profiles of the genes as clustering criterion. This has the advantage that also mutually invariant genes cluster together, as can be seen in the variance map by the blue areas.
In summary, SOM machine learning transforms the data into a multidimensional data landscape, which can be segmented into clusters of co-expressed genes. Moreover, 'portrayal' in terms of mosaic images visualizes this data landscape, which enables its intuitive perception. Figure 5 characterizes the spot modules containing between a few hundreds and a few thousands genes. The spot map visualizes the locations of the spot. The spot profile shows the mean expression amplitude of its genes in different samples. The segmentation of the data into spot modules so far lacks interpretation in terms of biological function. One simple option is gene set overrepresentation analysis to assign biological meaning to the spot modules identified. Statistical analysis using a collection of a few thousand gene sets selects the most enriched ones, i.e. sets whose genes accumulate in one or several spots. For example, one finds that activation of RAS associates with processes such as 'inflammation' and 'immune response', whereas its deactivation associates with 'transcription' and 'DNA binding'. MYC specifically activates mitochondrial processes and E2F3 upregulates 'cell cycle' and 'DNA repair'.
Functional Characteristics of the Spot-Modules

Gene Set Profiles and Maps
For a better overview over the enrichment characteristics of all spots we generated GSZ-heatmaps of GSZ-profiles referring to gene sets of a certain category which are overrepresented in the collection of spots and clusters ( Figure 6 ). The heatmap of the category 'biological process' identifies groups of gene sets which are specifically activated in the different sample groups: RAS activation and deactivation drives obviously most of the expression patterns, where, in general, RAS-positive processes associate with inflammation, stroma and chemotaxis and RAS-negative ones with cell proliferation, transcription and cell development. GSZ-overexpression profiles of selected gene sets are shown in the middle column of Figure 6 . Here, the mean expression of the gene of the set is compared with the mean expression of all the genes considered. The group-specific differential expression of the gene sets corresponds to the distribution of the genes of the set within the group? SOM map, as shown in the gene set maps in the right part of the figure. For example, genes of the set 'inflammatory response' accumulate in the top left corner of the map in the region of spot 'E' which, in turn, associates with upregulation in the RAS-group and overrepresentation of genes of this set (compare with Figure 5 ). The gene set maps reveal that part of the genes spread over regions of the map, which were assigned either to invariant expression profiles, or to spots, which show different characteristics. For example, genes of the gene set 'viral transcription' accumulate in spot 'B' but also in spot 'G', which associate with downregulation in the RAS-group and upregulation in the MYC-group, respectively. The respective GSZ-profile reflects these properties. Invariant genes can indicate false positive candidates, which were possibly selected into the gene set from the noise floor of data in the original study that defined the gene set. Another possible reason can be the fact that the design of the present study differs from the original one in a way that it affects a certain number of genes in a different way due to, e.g. different molecular mechanisms activated under the respective conditions. A further problem can arise, if genes from antagonistic modes of regulation are within the same gene set. In this case their expression changes mutually compensate each other giving rise to reduced amplitudes in the GSZ-profiles.
The analysis of gene sets characterizing 24 healthy human tissues in the lower part of Figure  6 reveals the interesting result that only three tissues clearly respond to the pathway activation signatures: Lymphocytes correspond to RAS-activation obviously because of common functions in immune response; mucosa and nervous tissue genes show relatively low expression in MYC activated cells paralleled by specific upregulations in BCAT-and E2F3-activated cells, respectively. In general, healthy tissues and oncogenic pathway activation cell lines address, obviously, different expression patterns. Finally, we studied signature gene sets for selected hallmarks of cancer (Figure 7) . RAS, E2F3 and partly MYC activations correspond to separate hallmarks, namely inflammation, proliferation and genomic instability, respectively. Note that angiogenesis and also proliferation relate to genes which accumulate in opposite corners of the map (see red frames), referring to RAS activation and deactivation as well. Here, the net effect of the gene set is reduced due to mutual compensations of the expression levels of genes from these antagonistic regulatory modes. Here a split of such sets according to these different modes is recommended for sake of increased sensitivity, e.g. into subsets up-and down-regulated in response to an external stimulus.
Pathway signal flow analysis
Gene sets collect functionally related genes without considering interactions between them. Activating and repressing interactions will induce, in the simplest case, anticorrelated expression changes and thus different enrichment characteristics, which will hamper functional interpretation of the data. One simple option to consider the type of interaction between genes is splitting of a functionally related gene set into one, containing only activating genes and another one, containing only repressing genes. A second option is consideration of the pathway topology and the calculation of the signal flow through the pathway in direction from the input to the sink nodes.
We selected the VEGF-(Vascular endothelial growth factor) and the Wnt-(Winglessrelated integration site) signaling pathways for illustration (Figure 8 and Figure 9) . Mapping of the genes of each pathway onto the SOM of oncogenic pathway activation indicates that they spread almost over all the regions of the map where only a few of them localize within the spots as indicated by the red circles. This result indicates that (i) most of the genes are not among the strong responders showing only moderate or even weak expression changes between the different conditions, and (ii) genes mutually change their expression in very different ways including correlated and anticorrelated switching modes. Note that the activation targets RAS, SRC and MYC are found within the spots, which were overexpressed in the respective conditions, namely the RAS_UP spot E, the SRC_UP spot J and the MYC_UP spot G, respectively (compare Figure  5 , Figure 8 and Figure 9 ).
For an overview we plotted the maximum PSF-values observed in the sink nodes of each of the different activation conditions: Accordingly, strongest effects were observed in the VEGFpathway for RAS and SRC activations, whereas maximum effect in the Wnt-pathway refers to MYC activation. For a more detailed view our program provides a colored pathway presentation where nodes with high and low PSF-values are colored in red and blue, respectively. SRC activation affects the PUK-Akt signaling branch in the lower part of the VEGF-signaling pathway with SRC as input node (see the red arrows in the lower part of Figure 8 ). In contrast, RAS activation gives rise to high PSF-values in the MAPK-signaling branch and of the PTGS2-gene sink. Hence, RAS and SRC activation conditions both affect VEGF-signaling however in different branches. These different branches support angionesis via different mechanisms: The PUK-Akt-branch supports cell survival, MAPK-signaling ensures proliferation and gene expression, whereas activation of the prostaglandin-endoperoxidase-synthase 2 (PTGS2) activates arachidonic acid metabolism and thus vascular cell permeability. Thus, pathway-centered PSF analysis enables the much more detailed view on cell functions, such as angionesis, than gene set analysis using the hallmark set 'angionesis' (compare with Figure 7) .
The Wnt-signaling pathway controls differentiation processes via cell fate decisions, proliferation and cell migration. The oncogenic activation conditions give rise to specific changes of the PSF-values in the pathway (Figure 9 ). Particularly, Wnt-signaling ends in a sink containing a whole battery of transcription factors activating the cell cycle such as MYC, JUN, FOSL1,
Figure 7. Selected gene set GSZ profiles and maps of the category 'hallmarks of cancer'
CCND1, PPARD and MMP7. Oncogenic activation selectively affects these different options (see the arrows in Figure 9 ).
Our program solution provides such group-specific analyses for all 168 pathways considered, thus enabling their detailed study. For an overview, the program generates a heatmap of the maximal PSF-values observed in each of the pathways. The heatmap reveals that RAS-activation affects by far the most pathways (Figure 10 ). However also combined activation by RAS&E2F3, RAS&MYC, MYC&E2F3 and also single activations by SRC and BCAT can be assigned. This heatmap enables preselection of pathways activated by a given experimental condition and/or assignment of a selected pathway to the different conditions studied.
FUNCTION DISCOVERY IN CANCER
In this section we study pathway activity in brain, blood and colon cancer. The tumor expression data were taken from public data repositories and described in detail in our previous publications Binder, et al., 2015; Hopp, Lembcke, Binder, & Wirth, 2013; Hopp, Wirth, Fasold, & Binder, 2013) . These papers also provide detailed function mining in terms of gene set analyses. Here we therefore focus on PSF analysis of the two example signaling pathways, already studied above and the PSF heatmaps.
Figure 9. (a) WNT signaling pathway; (b) WNT signaling pathway (continued)
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Glioma
Glioma is a type of brain tumor originating in the glial cells that surround and support neurons in the brain. High-grade gliomas are vascular tumors and have a tendency to infiltrate the surrounding tissue. Gliomas have poor prognosis with mean survival rates after first diagnosis between a few months and one-two years. Gene expression data of grade IV glioma were taken from the TCGA data base (The Cancer Genome Atlas), classified into four molecular subtypes, as defined by Verhaak et al. (Verhaak et al., 2010) , and to normal brain tissue as control and analyzed using SOM portrayal . An overview about the PSF data in glioma is given in Figure 11 . The heatmap reveals that brain tumor is characterized by deactivation of most of the KEGG-pathways compared with healthy brain. Only a limited set of pathways is activated in glioma. The proneural subtype of glioma (PN) shows high cell cycle activity and together with normal brain tissues activated ether lipid metabolism. The mesenchymal subtype (MES) shows unique activation of toll-like receptor signaling and of leucocyte transmembrane migration and together with tumors of the neuronal subtype (NL) active folate biosynthesis. The classical subtype (CL) activates the Erb-, Hippo-and estrogen receptor signaling pathways. In the lower part of Figure 11 we show the PSF-status of the VEGF signaling pathway. In all tumor subtypes the pathway is virtually inactive, whereas its MAPK-branch and the arachidonic acid metabolism sink are activated in healthy brain. 
B-Cell Lymphoma
Lymphomas are blood cancers in the lymph nodes and thus they are tumors of haematopoietic and lymphoid tissues. By histo-pathological diagnosis they divide into Burkitt's lymphoma (BL), diffuse large B-cell lymphoma (DLBCL), follicular lymphomas and others. Also from molecular view, lymphomas are very heterogeneous tumor entities. Gene expression data of germinal centre derived B-cell lymphomas were taken from Hummel et al. (Hummel et al., 2006) and classified into four molecular subtypes as described in (Hopp, Lembcke, et al., 2013) . The PSF-activity heatmap indeed reveals diverse patterns of pathway activity in the different subtypes (Figure 12 ). Molecular Burkitt's lymphomas (mBL) show increased cell cycle activity and non-molecular BL Figure 11 . PSF pathway characteristics of glioblastoma (subsuming tumors 'others than mBL' where most of them belong to the DLBCL histological type), high levels of diverse metabolic activities. The two intermediate subtypes are assumed to form a sort of transition states between mBL and non-mBL. They are characterized, for example, by high PSF-values in the pathway 'fatty acid biosynthesis' (Intermediate subtype B, IntLB) or in the T-and B-cell receptor pathways (IntLA), respectively. Note also the diverse overlap between the intermediate subtypes and mBL on one hand and non-mBL on the other hand. Hence, the lymphomas express high diversity on pathway level. This result is further confirmed by the detailed look on the two selected pathways. Each subtype shows its specific activation pattern in the VEGF-pathway (see the arrows in Figure 12 ): For example, the MAPK/RAS branch is activated in the IntLB subtype, thus resembling the activating patterns in RAS-activated cell lines, discussed above. In contrast, the non-mBL subtype shows increased signal flow in the paxillin (PXN) sink and the associated function 'cell migration/focal adhesion'. Also the Wnt-pathway shows specific activation patterns: In the IntLB subtype one finds strong signal values of the aixin/DVL complex which potentially leads to activation of Wnt-downstream targets.
Note also that the activation patterns in the VEGF-and Wnt-signaling pathways partly resemble those of the cell line experiments (compare with Figure 8 and Figure 9 ). This property was used on gene set level to assign lymphoma to so-called pathway activation patterns (Bentink et al., 2008) .
Colon Cancer
Next we studied molecular subtypes of colorectal carcinoma (CRC). Expression data were taken from the TCGA-repository and assigned to the subtypes CIMP-high (CIMP_H), -low and cluster 3 (C3) and C4 as described in . The subtypes refer to the DNA-methylation status of the tumors where 'CIMP' stands for 'CpG island methylator phenotype'. We recently showed close resemblance between DNA-methylation and gene expression characteristics . The PSF heatmap in Figure 13 shows high PSF values in the CIMP_H subtype for the majority of pathways considered. The PSF-values then progressively decrease in the CIMP_L, C3 and C4 subtypes. The plot of the VEGF-pathway illustrates this trend: The PSF-activity of the RAS/MAPK branch progressively decreases in this direction. Oncogenic activation of this path, e.g. by KRAS mutations, is a hallmark of colorectal carcinomas. Loss of the Wnt pathway negative regulator APC is another molecular hallmark of human colorectal cancers giving rise to aberrant activation of Wnt signaling (Novellasdemunt, Antas, & Li, 2015; Voloshanenko et al., 2013) . PSF-analysis of the Wnt-pathway confirms this expectation: All CRCsubtypes show a relatively high level of PSF in this pathway ( Figure 13 ). Interestingly, it reveals deactivation of the DVL and aixin complexes in CIMP_H and particularly of the component casein kinase 1-alpha (CSNK1a) which is assumed to serve as biomarker for invasiveness of CRC (Elyada et al., 2011) . The opposite state, namely high PSF-values of these genes is found in C3-type cancers. Hence, Wnt-function seems to be modulated in the different subtypes of CRC by mutations and/or epimutations (Novellasdemunt, et al., 2015) .
Common Activation Patterns in Glioma, Lymphoma and CRC
In the previous sections we performed knowledge discovery separately in pathway activation data taken from cell line experiments and in tumor data of three cancer entities by means of gene set and pathway analyses. Partly we found similar activation patterns, e.g. for RAS-activation in cell lines and colon cancer which suggests similar underlying molecular mechanisms. For the joint knowledge discovery of the three cancer entities we again make use of the cell line activation gene expression data, but now in terms of enrichment of signature gene sets characterizing B-cell lymphoma, glioma and colon cancer. The cancer gene sets were taken from a large collection of papers dealing with gene expression characteristics of the cancer types under study. The clustered heatmaps in Figure 14 reveal common (de-)activation patterns in the three cancer entities referring, for example, to RAS-and/or MYC-activation in the cell lines. Roughly we identified four different activation patterns: I) Pattern I is characterized by deactivated MYC and RAS associated genes. It is found in lymphomas with a stromal expression signature, gliomas of the PN subtype and in non-hypermethylated CRC. II) Pattern II shows high MYC activity and associates with high energy metabolism and poor prognosis cancers in agreement with (Wolfer et al., 2010) . III) The third pattern is found in DNA-methylator phenotypes and is characterized by low MYC and high RAS activations. IV) Pattern IV shows RAS activation and is found in diverse subtypes showing immune response signatures in brain and B-cell cancers. This result illustrates the fact that there exist obviously only a limited number of options for cellular responses to aberrant expression changes, despite the diversity of individual expression patterns in the different cancer subtypes. Recall that cancer is often called a disease of genomic defects that dys-regulate cellular functionalities and this way shape Darwinian evolution of malignant cell clones under selective pressure exerted by the (micro-) environment, medication and other factors. These processes then result in a heterogeneous spectrum of cancer phenotypes which, however, seem to agree partly between different cancer entities in terms of pathway activation patterns studied here. This result supports the hallmark of cancer view (Hanahan & Weinberg) however on a molecular, pathway centered level. Accordingly, almost all cancer types are char- 
CONCLUSION AND OUTLOOK
We illustrated the performance of two methods of knowledge discovery in large gene-centered expression data sets addressing oncogenic pathway activation in cell line experiments and patient cohort studies of three tumor entities. Both methods provide information about biological functions associated with subgroups of samples showing specific expression patterns. Gene set analysis links the multidimensional expression landscapes of the studied samples with the expression signature of sets of genes of known functional context. In contrast, the PSF-method directly maps the expression data onto pathway topologies of interacting genes. Both methods complement each other, where GSA is better suited for a general overview over the functional patterns, whereas PSF enables the detailed study of selected pathways.
GSA is based mostly on less specific information about the respective genes, which are often obtained empirically and neglects interactions between the genes. Signature genes extracted from one study can be easily used as gene set in another study to identify common biological functions. Hence, GSA is a robust approach that is based on minimum amount of information about the gene sets. This strength of GSA sometimes becomes problematic, namely if the genes of opposite differential expression are collected into the same gene set. In this case their sumeffect (either in terms of overexpression or overrepresentation) is reduced and, in worst case, is mostly compensated suggesting lack of association. Especially large gene sets of hundreds to thousands of genes are prone to this problem. Another problem is related to the fact that also sets of randomly collected genes (without functional context) can provide acceptable enrichment scores (Venet, Dumont, & Detours, 2011) . Here, one needs appropriate statistics for testing the null hypothesis.
PSF, in contrast, enables a detailed view on pathway (de-)activation in the data under study. It directly provides information about the activity status in different branches and/or sinks of the pathway. This pathway centered view is important especially in cancer research, because oncogenic dysfunction often associates with aberrant functionalities of selected pathways. Pathways usually refer to interactions between the respective proteins, i.e. the transcribed and translated products of gene expression. Using gene expression data, one however, neglects possible posttranscriptional and posttranslational modifications. Because of simple combination rules, the PSF algorithm provides only a qualitative evaluation of the activity level of the pathways selected. In this paper we demonstrated the impact of the methods to discover aberrant biological functions in selected cancer entities. The pathways shown were chosen as proof-of-principle examples.
We also demonstrated the strength of SOM machine learning in analyzing and discovering novel patterns in large heterogeneous data sets (Libbrecht & Noble, 2015) . We here used gene expression data. All methods, GSA and SOM, are generally applicable to other -omics, such as proteomics, genomics or epigenomics, as was demonstrated in previous applications (see (H Binder & Wirth, 2014) for an overview). PSF, in this case, however, requires modification of the interaction rules because, e.g. DNA-methylation or mutations of the genes involved, possibly will change the type of interactions.
